Report: Promising cell type represents new frontier for treating disease
A type of cell drawn from certain body tissues shows enormous potential to treat a range of diseases in the United States and Europe, but it must first receive federal approval as a regulated pharmaceutical.
Researchers discover effective way to generate powerful blood cells for immunotherapy
Scientists at the University of Wisconsin School of Medicine and Public Health have found a potentially improved method for creating T cells to treat cancer and infections.
UW researchers identify arterial hemogenic endothelial cells that can function as lymphoid precursors
Scientists at the University of Wisconsin School of Medicine and Public Health have used human stem cells to make blood-forming cells and demonstrated that they can function as lymphoid precursors, or the earliest cells from which various immune cells arise.
Researchers develop ways to identify potency of certain stem-cell treatments
Two new methods have been developed to test the health and potency of cells grown in a lab for use in some stem-cell treatments, which could lead to far more effective prediction of potency for clinical trials.
UW study uses ‘bio-panning’ to find human antibodies for brain cancer stem cells
Using a method described as similar to panning for gold, Carbone Cancer Center scientists discovered human antibodies for the cancer stem cells of glioblastoma, one of the most difficult brain cancers to treat.
Darcie Moore receives grant to study how brain cells age
A new grant of $100,000 will allow Dr. Darcie Moore to study how neural stem cells age, and how this can lead to cognitive decline and other maladies of old age.
Researchers discover how two gene enhancers control blood cell development
A group of researchers from the University of Wisconsin School of Medicine and Public Health (SMPH) has unearthed a critical process in how healthy red blood cells are produced.
Viral infection found to increase therapeutic resistance of glioblastoma cells
A common human virus, cytomegalovirus (CMV), can convert glioblastoma (GBM) brain cancer cells into cancer stem cells with higher therapeutic resistance, according to a new study by University of Wisconsin Carbone Cancer Center researchers.